Literature DB >> 29707909

Evolving concepts in classification of systemic vasculitis: where are we and what is the way forward?

Richard A Watts1,2,3.   

Abstract

The classification of the systemic vasculitides has been controversial for several decades. The Chapel Hill consensus Conference definitions originally developed in 1994, but revised and extended in 2012 are now widely accepted. The American College of Rheumatology (ACR) criteria were first published in 1990, are now generally accepted to be out of date and new criteria are needed. More recently the classical division of the ANCA vasculitides using clinical phenotype has come under scrutiny with evidence from epidemiological, genetic and outcome studies that perhaps these conditions should be classified on the basis of ANCA specificity into PR3-ANCA positive and MPO-ANCA positive groups. The traditional distinction between giant cell arteritis and Takayasu arteritis has been questioned and some recent studies of GCA have included patients with only extra-cranial disease. The Diagnostic and Classification Criteria of Vasculitis study (DCVAS) will provide new validated classification criteria for the systemic vasculitides.
© 2018 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  zzm321990ANCAzzm321990; classification criteria; vasculitis

Mesh:

Year:  2018        PMID: 29707909     DOI: 10.1111/1756-185X.13304

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  3 in total

Review 1.  Childhood- Versus Adult-Onset Primary Vasculitides: Are They Part of the Same Clinical Spectrum?

Authors:  Renato Ferrandiz-Espadin; Manuel Ferrandiz-Zavaler
Journal:  Curr Rheumatol Rep       Date:  2019-08-29       Impact factor: 4.592

2.  The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey.

Authors:  Luis Corral-Gudino; Elvira González-Vázquez; Ismael Calero-Paniagua; Laura Pérez-Garrido; Ivan Cusacovich; Alicia Rivas-Lamazares; Alba Quesada-Moreno; Ana González-Fernández; Damian Mora-Peña; Jose Luis Lerma-Márquez; Javier Del-Pino-Montes
Journal:  Rheumatol Int       Date:  2019-08-05       Impact factor: 2.631

3.  Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes.

Authors:  Frans Wiberg; Nazanin Naderi; Aladdin J Mohammad; Carl Turesson
Journal:  Rheumatology (Oxford)       Date:  2021-12-24       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.